Diabetes Pen Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The diabetes pen market size has grown strongly in recent years. It will grow from $29.24 billion in 2024 to $31.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to managing scarce water resources, ageing water infrastructure, escalating call for quality water services, rising demand for smart water solutions, improving efficiency in operation.

The diabetes pen market size is expected to see strong growth in the next few years. It will grow to $40.17 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growing population and urbanization, increasing water pollution and contamination, need for efficient resource management, need for accurate and real-time water data, increasing demand for water reuse and recycling. Major trends in the forecast period include advancements in digital technologies such as ai and ml, increasing adoption of iot and cloud computing, pressing need to address water-related challenges, increasing investment in water infrastructure, escalating digitization of the utility sector.

The growing prevalence of diabetes globally is expected to drive the expansion of the diabetes pen market in the coming years. Diabetes encompasses a group of chronic metabolic disorders marked by high blood sugar levels (hyperglycemia). Diabetes pens are insulin delivery devices that provide more precise dosing, improved adherence, and reduced risk of hypoglycemia. These pens are also associated with less pain at the injection site, making them a preferred choice for individuals with diabetes who need insulin. For example, the American Diabetes Association, a US-based professional organization, reported in May 2023 that, in 2021, the age-adjusted prevalence of Impaired Glucose Tolerance (IGT) among adults aged 20-79 was 9.1% (464 million). This figure is projected to rise to 10% (638 million) by 2045. Consequently, the increasing global incidence of diabetes is fueling the growth of the diabetes pen market.

Key players in the diabetes pen market are focusing on developing innovative products, such as virtually painless injections, to improve the user experience. A virtually painless injection is a method specifically designed to reduce discomfort during medication administration, enhancing patient comfort and making insulin management easier for individuals without fear or pain. For example, in May 2022, Roche AG, a Switzerland-based medical equipment company, introduced ACCU-FINE pen needles. These needles are designed to improve the insulin delivery process by providing a virtually painless injection, thereby enhancing compliance and health outcomes for people with diabetes.

In September 2023, Abbott Laboratories, a US-based healthcare company, acquired Bigfoot Biomedical Inc. This strategic acquisition is poised to bolster Abbott's presence in the diabetes market by expanding its product offerings and gaining access to Bigfoot Biomedical's customer base. The acquisition aims to improve diabetic care and patient outcomes through the integration of knowledge and technologies. Bigfoot Biomedical Inc., based in the US, specializes in diabetes management systems, including insulin pens and smart pen caps.

Major companies operating in the diabetes pen market report are F. Hoffman La Roche AG, Sanofi S.A., Astra Zeneca PLC, Fujitsu Limited, Eli Lilly and Company, Bayer Cropscience Ltd., Ericsson, Novo Nordisk A/S, BD, Bristol-Myers Squibb, Teruma Medical Corporation, Smiths Group plc., Greinier Bio One International GmBH (U.S.), YPSOMED, Owen Mumford Ltd., WOCKHARDT, Nipro Europe Group Companies, Biocon, Copernicus, Mannkind Corporation, Jiangsu Delfu medical device Co., HTL-STREFA Inc., DeepSig, Injex UK Ltd.

North America was the largest region in the diabetes pen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes pen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diabetes pen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes pen market includes revenues earned by entities by insulin delivery, cartridge or prefilled, and dosing mechanism. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes pen market also includes sales of fixed-dose pens, multi-dose pens, and adjustable-dose pens for providing select the desired amount of insulin to be injected services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

A diabetes pen is a medical device specifically designed for administering insulin to individuals with diabetes, serving as an alternative to traditional insulin delivery methods such as vial and syringe. It offers a convenient and user-friendly option, allowing individuals with diabetes to self-administer insulin discreetly and in a portable manner.

The primary products associated with diabetes pens include insulin pens and pen needles. Insulin pens are widely used as convenient tools for managing blood sugar levels in people with diabetes, offering simplicity in measuring and administering insulin. They come in both reusable and disposable options for insulin, glucagon-such as peptide-1, growth hormones, fertility, and osteoporosis treatment, and are distributed through various channels such as retail pharmacies, online medical stores, and diabetes clinics.

The diabetes pen market research report is one of a series of new reports that provides diabetes pen market statistics, including diabetes pen industry global market size, regional shares, competitors with a diabetes pen market share, detailed diabetes pen market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes pen industry. This diabetes pen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.